Citation Impact
Citing Papers
Novel Role of Thromboxane Receptors β Isoform in Bladder Cancer Pathogenesis
2008
Phase III Study Comparing Cisplatin Plus Gemcitabine With Cisplatin Plus Pemetrexed in Chemotherapy-Naive Patients With Advanced-Stage Non–Small-Cell Lung Cancer
2008 Standout
FoxOs Enforce a Progression Checkpoint to Constrain mTORC1-Activated Renal Tumorigenesis
2010 StandoutNobel
Residual lung lesions after completion of chemotherapy for gestational trophoblastic neoplasia: should we operate?
2005
Infertility rates following POMB/ACE chemotherapy for male and female germ cell tumours – a retrospective long-term follow-up study
2003
Induction of Mxi1-SRα by FOXO3a Contributes to Repression of Myc-Dependent Gene Expression
2007
Genital human papillomavirus infection in men
2005
Outcome of radical cystectomy for invasive bladder cancer
2000
The multifaceted roles of glycogen synthase kinase 3β in cellular signaling
2001 Standout
Function of the c-Myc Oncogenic Transcription Factor
1999
Sperm banking and assisted reproduction treatment for couples following cancer treatment of the male partner
2001
The Mad Side of the Max Network: Antagonizing the Function of Myc and More
2006
Update on Phosphodiesterase (PDE) Isoenzymes as Pharmacologic Targets in Urology: Present and Future
2006
Renal Cell Carcinoma Guideline
2007
2000 Update of Recommendations for the Use of Hematopoietic Colony-Stimulating Factors: Evidence-Based, Clinical Practice Guidelines
2000
Marine natural products
1990 Standout
The Role of MicroRNAs in Human Diseases
2013
Gestational trophoblastic disease
2010 Standout
Efficacy and Safety of Tadalafil Monotherapy for Lower Urinary Tract Symptoms Secondary to Benign Prostatic Hyperplasia: A Meta-Analysis
2013 Standout
Proliferation, cell cycle and apoptosis in cancer
2001 StandoutNature
Erectile Dysfunction and Lower Urinary Tract
2008
Quadrivalent Vaccine against Human Papillomavirus to Prevent Anogenital Diseases
2007 Standout
Molecular mechanisms of cisplatin resistance
2011 Standout
Therapeutic potential of β-arrestin- and G protein-biased agonists
2010 StandoutNobel
Second Cancers Among 40 576 Testicular Cancer Patients: Focus on Long-term Survivors
2005 Standout
Primary breast cancer: ESMO Clinical Practice Guidelines for diagnosis, treatment and follow-up
2010 Standout
The 2005 International Society of Urological Pathology (ISUP) Consensus Conference on Gleason Grading of Prostatic Carcinoma
2005 Standout
Cystic Trophoblastic Tumor
2004
cGMP-Dependent Protein Kinases and cGMP Phosphodiesterases in Nitric Oxide and cGMP Action
2010 Standout
Testicular germ-cell tumours in a broader perspective
2005 Standout
Overview of MicroRNA Biogenesis, Mechanisms of Actions, and Circulation
2018 Standout
p21 in cancer: intricate networks and multiple activities
2009 Standout
Chromosomes, genes, and development of testicular germ cell tumors
2004
Predicting Recurrence and Progression in Individual Patients with Stage Ta T1 Bladder Cancer Using EORTC Risk Tables: A Combined Analysis of 2596 Patients from Seven EORTC Trials
2006 Standout
STATs in oncogenesis
2000 Standout
Oxaliplatin for the treatment of cisplatin-resistant cancer: A systematic review
2007
Systematic Review of Adrenalectomy and Lymph Node Dissection in Locally Advanced Renal Cell Carcinoma
2013
Molecular genetics of prostate cancer
2000
Apoptosis
2002 Standout
Myelodysplastic syndrome and acute myeloid leukemia after autotransplantation for lymphoma: a multicenter case-control study
2002
Hematopoietic Stem-Cell Transplantation
2006 Standout
Tumour-educated macrophages promote tumour progression and metastasis
2004 Standout
Reflecting on 25 years with MYC
2008 Standout
P53 as a prognostic marker for bladder cancer: a meta-analysis and review
2005
Crucial role of p53-dependent cellular senescence in suppression of Pten-deficient tumorigenesis
2005 StandoutNature
Early breast cancer: ESMO Clinical Practice Guidelines for diagnosis, treatment and follow-up
2019 Standout
EAU Guidelines on Renal Cell Carcinoma: 2014 Update
2015 Standout
Cell cycle, CDKs and cancer: a changing paradigm
2009 Standout
The 2016 WHO Classification of Tumours of the Urinary System and Male Genital Organs—Part A: Renal, Penile, and Testicular Tumours
2016 Standout
Medical Treatment of Advanced Testicular Cancer
2008
Sperm cryopreservation before cancer chemotherapy helps in the emotional battle against cancer
2005
The Human Plasma Proteome
2002 Standout
Renal cell carcinoma
2017 Standout
Removal of cytostatic drugs from aquatic environment: A review
2013 Standout
PDE5 inhibitors beyond erectile dysfunction
2007
The history and future of targeting cyclin-dependent kinases in cancer therapy
2015 Standout
Prognostic factors and reporting of prostate carcinoma in radical prostatectomy and pelvic lymphadenectomy specimens
2005
Relationship between Schistosomiasis and Bladder Cancer
1999
Guidelines for the diagnosis and treatment of chronic lymphocytic leukemia: a report from the International Workshop on Chronic Lymphocytic Leukemia updating the National Cancer Institute–Working Group 1996 guidelines
2008 Standout
Augmentation of T Cell Levels and Responses Induced by Androgen Deprivation
2004 StandoutNobel
American Society of Clinical Oncology Recommendations on Fertility Preservation in Cancer Patients
2006 Standout
The MAX-interacting transcription factor network
2006
Rituximab-CHOP Versus CHOP Alone or With Maintenance Rituximab in Older Patients With Diffuse Large B-Cell Lymphoma
2006 Standout
Reduced tissue macrophage population in the lung by anticancer agent cyclophosphamide: restoration by local granulocyte macrophage–colony-stimulating factor gene transfer
2002
Vanilloid (Capsaicin) Receptors and Mechanisms
1999 Standout
2002 Guidelines for the Use of Antimicrobial Agents in Neutropenic Patients with Cancer
2002 Standout
Heritability of Prostate-Specific Antigen and Relationship with Zonal Prostate Volumes in Aging Twins*
2000
Radical Cystectomy for Bladder Cancer Today—A Homogeneous Series Without Neoadjuvant Therapy
2003 Standout
Copper chelation in cancer therapy using tetrathiomolybdate: an evolving paradigm
2009
Long-Term Medical Care of Testicular Cancer Survivors
2002
Molecular determinants of treatment response in human germ cell tumors.
2003
The Max Network Gone Mad
2001
Impact of Natural Products on Developing New Anti-Cancer Agents
2009 Standout
p53 Immunohistochemistry as a Prognostic Marker in Bladder Cancer
2000
Genital Human Papillomavirus Infection in Men
2007
Hoxb13is required for normal differentiation and secretory function of the ventral prostate
2003 StandoutNobel
Advances in Copper Complexes as Anticancer Agents
2013 Standout
Bioactive Peptides and Depsipeptides with Anticancer Potential: Sources from Marine Animals
2012
Do cytotoxic chemotherapy drugs discharged into rivers pose a risk to the environment and human health? An overview and UK case study
2007
Cyclin-Dependent Kinase Inhibitor p27 As a Prognostic Biomarker and Potential Cancer Therapeutic Target
2010
Flavonoids in Cancer and Apoptosis
2018 Standout
The World Health Organization (WHO) classification of the myeloid neoplasms
2002 Standout
Therapy-Related Acute Leukemia
2000
Early onset of neoplasia in the prostate and skin of mice with tissue-specific deletion of Pten
2004 StandoutNobel
The overactive bladder: Pharmacologic basis of drug treatment
1997
Natural Products As Sources of New Drugs over the 30 Years from 1981 to 2010
2012 Standout
The incidence of secondary leukemias.
1999
American Society of Clinical Oncology Treatment of Unresectable Non–Small-Cell Lung Cancer Guideline: Update 2003
2003 Standout
WAF1/p21 Protein Expression Is an Independent Prognostic Indicator in Superficial and Invasive Bladder Cancer
2000
Cyclin-Dependent Kinase Pathways As Targets for Cancer Treatment
2006
Management of the Adrenal Gland During Partial Nephrectomy
2009
Systematic reviews: CRD's guidance for undertaking reviews in health care
2010 Standout
Works of M.A. Kuczyk being referenced
The MXI1 tumor suppressor gene is not mutated in primary prostate cancer.
1998
Secondary leukemia following high cumulative doses of etoposide in patients treated for advanced germ cell tumors.
1998
The prognostic value of p53 for long-term and recurrence-free survival following radical prostatectomy
1998
Induction of apoptosis by flavopiridol unrelated to cell cycle arrest in germ cell tumour derived cell lines
2005
Recent strategies for the use of paclitaxel in the treatment of urological malignancies
1998
Prostate-specific antigen density — a reliable parameter for the detection of prostate cancer?
1996
Future prospects in the chemotherapy of metastatic nonseminomatous testicular germ-cell cancer
1999
Treatment of patients with metastatic germ cell tumors relapsing after high-dose chemotherapy
2001
Predictive value of decreased p27Kip1 protein expression for the recurrence-free and long-term survival of prostate cancer patients
1999
p53 overexpression as a prognostic factor for advanced stage bladder cancer
1995
Late relapse after treatment for nonseminomatous testicular germ cell tumors according to a single center-based experience
2004
The need for routine adrenalectomy during surgical treatment for renal cell cancer: the Hannover experience
2002
Wirksamkeit von Multikinaseinhibitoren in der Therapie des fortgeschrittenen Nierenzellkarzinoms
2007
Cyclic nucleotide phosphodiesterase (PDE) isoenzymes in the human detrusor smooth muscle
1996
Long-term effects on sexual function and fertility after treatment of testicular cancer
1999
Hematopoietic growth factors and treatment of testicular cancer: Biological interactions, routine use and dose-intensive chemotherapy
1996
Detection of viral HPV 16 DNA in prostate cancer and benign prostatic hyperplasia by quantitative PCR-directed analysis
2000
Postchemotherapy resections of residual masses from metastatic non-seminomatous testicular germ cell tumors
1997
Detection of p53 tumor-suppressor-gene protein in bladder tumors and prostate cancer: possible clinical implications
1994
Over expression of the P53 Oncoprotein in Carcinoma in Situ of the Testis
1994
399 IS THERE A NEED TO FURTHER SUBCLASSIFY PT2 RENAL CELL CANCERS AS IMPLEMENTED BY THE REVISED 7TH TNM VERSION?
2011
Prognostic value of p27Kip1 and p21WAF/Cip protein expression in muscle invasive bladder cancer.
1999
Hsa-mir-124-3 CpG island methylation is associated with advanced tumours and disease recurrence of patients with clear cell renal cell carcinoma
2013
Activity of Oxaliplatin in Patients With Relapsed or Cisplatin-Refractory Germ Cell Cancer: A Study of the German Testicular Cancer Study Group
2002